Amgen has settled with the Federal Trade Commission after the US regulator in May had tried blocking the California drugmaker’s proposed nearly $28 billion acquisition of Horizon Therapeutics.
The deal is expected to close early next quarter now, the companies said Friday morning.
Amgen and Horizon entered into a…
Click here to view original post
